Drug profile · INN
selpercatinib
RETEVMO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
selpercatinib (RETEVMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN selpercatinib
Brand RETEVMO
Route ORAL
Formulation CAPSULE
ATC code L01EX22
Frequently asked questions
What is selpercatinib?
selpercatinib (RETEVMO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for selpercatinib?
RETEVMO is a marketed brand name for selpercatinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of selpercatinib?
selpercatinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.